Potentiation of the D2 mutant motor phenotype in mice lacking dopamine D2 and D3 receptors

Neuroscience

Volumn 91, Issue 3, 1999, Pages 911-924

  Jung, M Y ^a   Skryabin, B V ^a   Arai, M ^b   Abbondanzo, S ^c   Fu, D ^a   Brosius, J ^a   Robakis, N K ^a   Polites, H G ^c   Pintar, J E ^b   Schmauss, C ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c SANOFI   (France)

Author keywords

Dopamine D2 receptors; Dopamine D3 receptors; Dopamine metabolism; Gene targeting; Homologous recombination; Locomotion

Indexed keywords

DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; RECEPTOR SUBTYPE; DOPAMINE; DRD3 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ARTICLE; COMPARATIVE STUDY; CORPUS STRIATUM; DOPAMINE METABOLISM; DOPAMINERGIC ACTIVITY; DOPAMINERGIC SYSTEM; GENE DISRUPTION; GENE TARGETING; LOCOMOTION; LONG TERM POTENTIATION; MOUSE; NONHUMAN; PHENOTYPE; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; BRAIN; GENETICS; HETEROZYGOTE; METABOLISM; MOTOR ACTIVITY; MOUSE MUTANT; NEWBORN; PHYSIOLOGY;

ANIMALS; ANIMALS, NEWBORN; BRAIN; DOPAMINE; HETEROZYGOTE; MICE; MICE, KNOCKOUT; MOTOR ACTIVITY; PHENOTYPE; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3;

EID: 0032587026     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00705-2     Document Type: Article

References (37)

1. Accili D., Fishburn C.S, Drago J., Steiner H., Lachowicz J.E, Park B.-H., Gauda E.B, Lee E.J, Cool M.H, Sibley D.R, Gerfen C.R, Westphal H., Fuchs S. A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice. Proc. natn. Acad. Sci. U.S.A. 93:1996;1945-1949.
2. 2 receptors. Nature. 377:1995;424-428.
3. 2 dopamine receptor cDNA. Nature. 336:1988;783-787.
4. 3 dopamine receptors. Neuropsychopharmacology. 12:1995;335-345.
5. Chirgwin J.M, Przybyla A.E, MacDonald R.J, Rutter W.J Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 18:1979;5294-5299.
6. 3 receptors. J. med. Chem. 37:1994;4245-4250.
7. Civelli O., Bunzow J.R, Grandy D.K Molecular diversity of the dopamine receptors. A. Rev. Pharmac. Toxicol. 32:1993;281-307.
8. 1A dopamine receptors. Proc. natn. Acad. Sci. U.S.A. 91:1994;12,564-12,568.
9. Essig E.C, Kilpatrick I.C Influence of acute and chronic haloperidol treatment on dopamine metabolism in the rat caudate-putamen, prefrontal cortex and amygdala. Psychopharmacology. 104:1991;194-200.
10. 3 dopamine receptor generated by alternative splicing in the third cytoplasmic loop. J. biol. Chem. 268:1993;5872-5877.
11. 3 receptor gene: an additional intron and an mRNA variant. DNA Cell Biol. 14:1995;485-492.
12. 2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science. 250:1990;1429-1432.
13. Gingrich J.A, Caron M.G Recent advances in the molecular biology of dopamine receptors. A. Rev. Neurosci. 16:1993;299-321.
14. 3 receptors. Eur. J. Pharmac. 272:1995;R1-R3.
15. 2 dopamine receptor gene expression in the rat striatum during ontogeny: an in situ hybridization study. Devl Brain Res. 60:1991;79-87.
16. Haycock J.W, Meligeni J.A, Bennett W.F, Waymire J.C Phosphorylation and activation of tyrosine hydroxylase mediate the acetylcholine-induced increase in catecholamine biosynthesis in adrenal chromaffin cells. J. biol. Chem. 257:1982;12,641-12,648.
17. Haycock J.W, Haycock D.A Tyrosine hydroxylase in rat brain dopaminergic nerve terminals. J. biol. Chem. 266:1991;5650-5657.
18. 2 dopamine receptor-deficient mice is determined by gene dosage, genetic background, and developmental adaptations. J. Neurosci. 18:1998;3470-3479.
19. 125I] (+) trans-7-OH-PIPAT in rat brain. NS Arch. Pharmac. 350:1994;611-617.
20. 3 receptor: Chinese hamsters or Chinese whispers. Trends pharmac. Sci. 15:1994;46-47.
21. 2 dopamine receptors: visualization and cellular expression patterns in motor and limbic structures. Synapse. 20:1995;325-337.
22. 3 receptor in rat brain using 7-[3H]hydroxy-N,N-di-n-propyl-2-aminotetralin. Proc. natn. Acad. Sci. U.S.A. 89:1992;8155-8159.
23. 2 receptors. Nature. 388:1997;586-589.
24. Meader-Woodruff J.H, Grandy D.K, Van Tol H.H, Damask S.P, Little K.Y, Civelli O., Watson S.J Dopamine receptor gene expression in the human medial temporal lobe. Neuropharmacology. 10:1994;239-248.
25. 3 receptor dimers and tetramers in brain and in transfected cells. J. biol. Chem. 272:1997;29,229-29,237.
26. 2 receptors to mesostriatal regions of the human forebrain. Proc. natn. Acad. Sci. U.S.A. 91:1994;11,271-11,275.
27. Pothos E.N, Creese I., Hoebel B.G Restricted eating with weight loss selectively decreases extracellular dopamine in the nucleus accumbens and alters dopamine responses to amphetamine, morphine, and food intake. J. Neurosci. 15:1995;6640-6650.
28. Rudnicki M.A, Braun T., Hinuma S., Jaenisch R. Inactivation of MyoD in mice leads to up-regulation of the myogenic HLH gene Myf-5 and results in apparently normal muscle development. Cell. 71:1992;383-390.
29. 3-receptor pre-mRNA in chronic schizophrenia. J. Neurosci. 16:1996;7902-7909.
30. 3 receptors and σ sites in the bovine caudate nucleus. Eur. J. Pharmac. 242:1993;R1-R3.
31. See R.E Striatal dopamine metabolism increases during long-term haloperidol administration in rats but shows tolerance in response to acute challenge with raclopride. Neurosci. Lett. 129:1991;265-268.
32. Skryabin B.V, Schmauss C. Enhanced selection for homologous-recombinant embryonic stem cell clones with a neomycine phosphotransferase gene in antisense orientation. Transgenic Res. 6:1997;27-35.
33. 3 dopamine receptor mRNA is widely expressed in the human brain. Brain Res. 779:1998;58-74.
34. Thomas K.R, Capecchi M.R Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell. 51:1987;503-512.
35. 1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses. Cell. 79:1994;729-742.
36. 1 receptor mutant mice. Cell. 79:1994;945-955.
37. 2 receptors. Neuron. 19:1997;837-848.